Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1991 Jan;59(1):229–233. doi: 10.1128/iai.59.1.229-233.1991

Properties of a rat monoclonal antibody reactive with both the mannan of Candida species and the O-antigen 6,7 polysaccharide of serogroup C1 salmonellae.

N A Nnalue 1, A Weintraub 1, A A Lindberg 1
PMCID: PMC257731  PMID: 1702760

Abstract

Monoclonal antibody MASC1-MR9 of isotype immunoglobulin M was generated in LOU/C rats by immunization with heat-killed Salmonella thompson (serogroup C1, O-antigen 6,7 lipopolysaccharide) bacteria which had been further enriched for O-antigen by coating with homologous lipopolysaccharide. Eight monoclonal antibodies were selected by screening against the lipopolysaccharide of S. thompson. In a subsequent test against Candida mannan, only one antibody, MASC1-MR9, was reactive. Immunofluorescence microscopy of various yeasts and bacteria with MASC1-MR9 showed that this antibody bound to the surfaces of 142 of 148 Candida strains of 10 different species tested but failed to bind to the surface of Saccharomyces cerevisiae. The Candida strains which failed to bind MASC1-MR9 were all five strains of Candida krusei and the single strain of Candida utilis tested. Several (11 of 33) Salmonella strains belonging to serogroup C1 reacted with this antibody, as expected; however, 1 of 11 strains of Morganella morganii and 4 of 64 strains of Escherichia coli were also reactive. Serum-free supernatants of MASC1-MR9 agglutinated S. thompson, one strain of Salmonella choleraesuis, and 109 of 110 Candida strains tested. The immunochemical properties of MASC1-MR9 as studied by enzyme-linked immunosorbent inhibition assays show that it recognizes an epitope present in the mannan of Candida species as well as in the O-6,7 antigen of Salmonella species.

Full text

PDF
231

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alsina A., Mason M., Uphoff R. A., Riggsby W. S., Becker J. M., Murphy D. Catheter-associated Candida utilis fungemia in a patient with acquired immunodeficiency syndrome: species verification with a molecular probe. J Clin Microbiol. 1988 Apr;26(4):621–624. doi: 10.1128/jcm.26.4.621-624.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blinkhorn R. J., Adelstein D., Spagnuolo P. J. Emergence of a new opportunistic pathogen, Candida lusitaniae. J Clin Microbiol. 1989 Feb;27(2):236–240. doi: 10.1128/jcm.27.2.236-240.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bodey G. P. Candidiasis in cancer patients. Am J Med. 1984 Oct 30;77(4D):13–19. [PubMed] [Google Scholar]
  4. Brawner D. L., Cutler J. E. Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome. J Clin Microbiol. 1989 Jun;27(6):1335–1341. doi: 10.1128/jcm.27.6.1335-1341.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brawner D. L., Cutler J. E. Ultrastructural and biochemical studies of two dynamically expressed cell surface determinants on Candida albicans. Infect Immun. 1986 Jan;51(1):327–336. doi: 10.1128/iai.51.1.327-336.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Carlin N. I., Lindberg A. A. Monoclonal antibodies specific for O-antigenic polysaccharides of Shigella flexneri: clones binding to II, II:3,4, and 7,8 epitopes. J Clin Microbiol. 1983 Nov;18(5):1183–1189. doi: 10.1128/jcm.18.5.1183-1189.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cassone A., Torosantucci A., Boccanera M., Pellegrini G., Palma C., Malavasi F. Production and characterisation of a monoclonal antibody to a cell-surface, glucomannoprotein constituent of Candida albicans and other pathogenic Candida species. J Med Microbiol. 1988 Dec;27(4):233–238. doi: 10.1099/00222615-27-4-233. [DOI] [PubMed] [Google Scholar]
  8. Chew W. H., Theus T. L. Candida precipitins. J Immunol. 1967 Feb;98(2):220–224. [PubMed] [Google Scholar]
  9. Ekwall E., Svenson S. B., Lindberg A. A. Identification of salmonellae of serogroup C1 by immunofluorescence and co-agglutination with antiserum against an oligosaccharide-protein conjugate. J Med Microbiol. 1982 May;15(2):173–180. doi: 10.1099/00222615-15-2-173. [DOI] [PubMed] [Google Scholar]
  10. Galfrè G., Milstein C., Wright B. Rat x rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG. Nature. 1979 Jan 11;277(5692):131–133. doi: 10.1038/277131a0. [DOI] [PubMed] [Google Scholar]
  11. Gold J. W. Opportunistic fungal infections in patients with neoplastic disease. Am J Med. 1984 Mar;76(3):458–463. doi: 10.1016/0002-9343(84)90665-x. [DOI] [PubMed] [Google Scholar]
  12. Goodman D. S., Teplitz E. D., Wishner A., Klein R. S., Burk P. G., Hershenbaum E. Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol. 1987 Aug;17(2 Pt 1):210–220. doi: 10.1016/s0190-9622(87)70193-5. [DOI] [PubMed] [Google Scholar]
  13. Gorin P. A., Spencer J. F. Structural chemistry of fungal polysaccharides. Adv Carbohydr Chem Biochem. 1968;23:367–417. doi: 10.1016/s0096-5332(08)60172-1. [DOI] [PubMed] [Google Scholar]
  14. Lehmann P. F., Reiss E. Detection of Candida albicans mannan by immunodiffusion, counterimmunoelectrophoresis, and enzyme-linked immunoassay. Mycopathologia. 1980 Mar 17;70(2):83–88. doi: 10.1007/BF00443072. [DOI] [PubMed] [Google Scholar]
  15. Lindberg B., Leontein K., Lindquist U., Svenson S. B., Wrangsell G., Dell A., Rogers M. Structural studies of the O-antigen polysaccharide of Salmonella thompson, serogroup C1 (6,7). Carbohydr Res. 1988 Mar 15;174:313–322. doi: 10.1016/0008-6215(88)85100-0. [DOI] [PubMed] [Google Scholar]
  16. Luk J. M., Nnalue N. A., Lindberg A. A. Efficient production of mouse and rat monoclonal antibodies against the O antigens of Salmonella serogroup C1, using LPS-coated bacteria as immunogen. J Immunol Methods. 1990 May 25;129(2):243–250. doi: 10.1016/0022-1759(90)90445-2. [DOI] [PubMed] [Google Scholar]
  17. Maksymiuk A. W., Thongprasert S., Hopfer R., Luna M., Fainstein V., Bodey G. P. Systemic candidiasis in cancer patients. Am J Med. 1984 Oct 30;77(4D):20–27. [PubMed] [Google Scholar]
  18. Merz W. G., Evans G. L., Shadomy S., Anderson S., Kaufman L., Kozinn P. J., Mackenzie D. W., Protzman W. P., Remington J. S. Laboratory evaluation of serological tests for systemic candidiasis: a cooperative study. J Clin Microbiol. 1977 Jun;5(6):596–603. doi: 10.1128/jcm.5.6.596-603.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pensler J. M., Herndon D. N., Ptak H., Bonds E., Rutan T. C., Desai M. H., Abston S. Fungal sepsis: an increasing problem in major thermal injuries. J Burn Care Rehabil. 1986 Nov-Dec;7(6):488–491. [PubMed] [Google Scholar]
  20. SUMMERS D. F., GROLLMAN A. P., HASENCLEVER H. F. POLYSACCHARIDE ANTIGENS OF CANDIDA CELL WALL. J Immunol. 1964 Mar;92:491–499. [PubMed] [Google Scholar]
  21. Silverman S., Jr, Luangjarmekorn L., Greenspan D. Occurrence of oral Candida in irradiated head and neck cancer patients. J Oral Med. 1984 Oct-Dec;39(4):194–196. [PubMed] [Google Scholar]
  22. Spebar M. J., Pruitt B. A., Jr Candidiasis in the burned patient. J Trauma. 1981 Mar;21(3):237–239. doi: 10.1097/00005373-198103000-00007. [DOI] [PubMed] [Google Scholar]
  23. Suzuki M., Fukazawa Y. Immunochemical characterization of Candida albicans cell wall antigens: specific determinant of Candida albicans serotype A mannan. Microbiol Immunol. 1982;26(5):387–402. doi: 10.1111/j.1348-0421.1982.tb00189.x. [DOI] [PubMed] [Google Scholar]
  24. Svenungsson B., Lindberg A. A. Synthetic disaccharide-protein antigens for production of specific 04 and 09 antisera for immunofluorescence diagnosis of salmonella. Med Microbiol Immunol. 1977 May 18;163(1):1–11. doi: 10.1007/BF02126704. [DOI] [PubMed] [Google Scholar]
  25. Taschdjian C. L., Toni E. F., Hsu K. C., Seelig M. S., Cuesta M. B., Kozinn P. J. Immunofluorescence studies of candida in human reticuloendothelial phagocytes: implications for immunogenesis and pathogenesis of systemic candidiasis. Am J Clin Pathol. 1971 Jul;56(1):50–58. doi: 10.1093/ajcp/56.1.50. [DOI] [PubMed] [Google Scholar]
  26. Tojo M., Shibata N., Kobayashi M., Mikami T., Suzuki M., Suzuki S. Preparation of monoclonal antibodies reactive with beta-1,2-linked oligomannosyl residues in the phosphomannan-protein complex of Candida albicans NIH B-792 strain. Clin Chem. 1988 Mar;34(3):539–543. [PubMed] [Google Scholar]
  27. Walsh T. J., Salkin I. F., Dixon D. M., Hurd N. J. Clinical, microbiological, and experimental animal studies of Candida lipolytica. J Clin Microbiol. 1989 May;27(5):927–931. doi: 10.1128/jcm.27.5.927-931.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. de Repentigny L., Kuykendall R. J., Chandler F. W., Broderson J. R., Reiss E. Comparison of serum mannan, arabinitol, and mannose in experimental disseminated candidiasis. J Clin Microbiol. 1984 Jun;19(6):804–812. doi: 10.1128/jcm.19.6.804-812.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. de Repentigny L., Reiss E. Current trends in immunodiagnosis of candidiasis and aspergillosis. Rev Infect Dis. 1984 May-Jun;6(3):301–312. doi: 10.1093/clinids/6.3.301. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES